Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cancer

INDICATION: Cancer

Cell culture and mouse studies suggest adoptive transfer of blood-derived, ex vivo-modified memory NK cells could help treat cancers. Memory NK cells derived from cytomegalovirus

Read the full 260 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE